Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Equillium, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 9.92M | 9.12M | −799.1K (−8.1%) |
| Value | $7.44M | $6.75M | −$690.2K (−9.3%) |
New holders (1)
Institutions that held Equillium, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 36,287 | $26.9K | 0.00% |
Sold out (3)
Institutions that held Equillium, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deutsche Bank AG | 348,061 | $261.0K |
| US Bancorp | 494 | $371 |
| FMR LLC | 25 | $19 |